open access

Online first
Letter to the Editor
Published online: 2022-11-24
Get Citation

Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment?

Patoulias Dimitrios1, Athina Dimosiari1, Theodoros Michailidis2
DOI: 10.33963/KP.a2022.0272
·
Pubmed: 36446075
Affiliations
  1. Department of Internal Medicine, European Interbalkan Medical Center, Thessaloniki, Greece
  2. 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Thessaloniki, Greece

open access

Online first
Letter to the Editor
Published online: 2022-11-24

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Letter to the Editor

Published online

2022-11-24

Page views

52

Article views/downloads

111

DOI

10.33963/KP.a2022.0272

Pubmed

36446075

Authors

Patoulias Dimitrios
Athina Dimosiari
Theodoros Michailidis

References (5)
  1. Rola P, Włodarczak A, Włodarczak S, et al. Invasive assessment of coronary microvascular dysfunction in patients with long COVID: Outcomes of a pilot study. Kardiol Pol. 2022 [Epub ahead of print].
  2. Ikonomidis I, Pavlidis G, Katsimbri P, et al. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019; 108(10): 1093–1101.
  3. Ikonomidis I, Lekakis JP, Nikolaou M, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008; 117(20): 2662–2669.
  4. Holte E, Kleveland O, Ueland T, et al. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart. 2017; 103(19): 1521–1527.
  5. Siemieniuk RAc, Bartoszko JJ, Zeraatkar D, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020; 370: m2980.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl